Future Market Insights projects that between 2023 and 2033, the hyperphosphatemia market would grow rapidly. The global market for pharmaceuticals treating hyperphosphatemia is predicted to expand at a similar rate by 2033, when sales of these drugs are projected to reach US$ 20.24 billion. Various calcium-based phosphorus binders are being used in the present day …